Stay updated on Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded a Publications entry with a PubMed-cited article on the BTCRC-LUN17-127 Phase I/II trial of plinabulin with nivolumab and ipilimumab in recurrent SCLC; updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.4%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedLung cancer and related topics: MedlinePlus Genetics were removed from the page's topic navigation. The core study information remains unchanged.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded Lung cancer and related topics (MedlinePlus Genetics); updated page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.2%

- Check47 days agoChange DetectedAdded Revision: v3.4.3; removed Lung cancer and MedlinePlus Genetics topics; removed Revision: v3.4.2 from the topic list.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded related topics: Lung cancer and MedlinePlus Genetics.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.